Ovarian cancer: thrombosis prophylaxis during neoadjuvant chemotherapy

被引:0
|
作者
Clauss, R. Maria
机构
关键词
D O I
10.1055/a-2208-1843
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Unter der Therapie eines fortgeschrittenen Ovarialkarzinoms sind venose Thromboembolien (VTEs) haufig. Klinische Studien berichten, dass 8-28% der erkrankten Frauen im Rahmen einer neoadjuvanten Chemotherapie unter einem thromboembolischen Ereignis leiden. In Expertenkreisen wird daher schon langer uber eine generelle Thromboseprophylaxe wahrend der Chemotherapie-Phase im Vorfeld der Operation diskutiert.
引用
收藏
页码:103 / 104
页数:2
相关论文
共 50 条
  • [1] Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer
    McLaughlin, Hannah Dysinger
    Straubhar, Alli M.
    Rolston, Aimee
    McCool, Kevin
    Brackmann, Melissa
    Siedel, Jean Hansen
    McLean, Karen
    Reynolds, R. Kevin
    Uppal, Shitanshu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer
    McLaughlin, Hannah D.
    Greco, Patricia
    Straubhar, Alli M.
    Rolston, Aimee
    McCool, Kevin
    Brackmann, Melissa
    Siedel, Jean H.
    McLean, Karen
    Reynolds, R. Kevin
    Uppal, Shitanshu
    GYNECOLOGIC ONCOLOGY, 2023, 178 : 89 - 95
  • [3] Cost-Effectiveness of Venous Thromboembolism Prophylaxis During Neoadjuvant Chemotherapy for ovarian Cancer
    Ryan, Emma S.
    Havrilesky, Laura J.
    Salinaro, Julia R.
    Davidson, Brittany A.
    JCO ONCOLOGY PRACTICE, 2021, 17 (08) : E1075 - E1084
  • [4] Venous thromboembolism (VTE) in ovarian cancer during neoadjuvant chemotherapy: Is it time to start prophylaxis?
    Dal Molin, G. Z.
    Fleming, N. D.
    Fellman, B.
    Dood, R. L.
    Lara, O. D.
    LaFargue, C. J.
    Coleman, R. L.
    Soliman, P. T.
    Schmeler, K. M.
    Westin, S. N.
    Sood, A. K.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 155 - 155
  • [5] Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer
    Oxley, Samuel
    Ahmed, Sarah
    Baxter, Kathryn
    Blake, Dominic
    Braden, Victoria
    Brincat, Mark R.
    Bryan, Stacey
    Dilley, James
    Dobbs, Stephen
    Durden, Andrew
    Gomes, Nana
    Johnston, Ben
    Kaushik, Sonali
    Kokka, Fani
    Lockley, Michelle
    Lowe-Zinola, Jack
    Manchanda, Ranjit
    McCormick, Aiste
    Nott, Charlotte
    Owens, Gemma Louise
    Pandya, Aayushi
    Prince, Jessica
    Ryan, Neil
    Ryan, Nicole
    Sideris, Michail
    Tanna, Sameera
    Waters, Justin
    Zamesa, Nathan
    Thomas, Mari
    Olaitan, Adeola
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [6] Neoadjuvant Chemotherapy for Ovarian Cancer?
    Hasenburg, A.
    GYNAKOLOGE, 2019, 52 (09): : 638 - 638
  • [7] Neoadjuvant chemotherapy in ovarian cancer
    Camci, C
    Balat, O
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2002, 23 (05) : 437 - 441
  • [8] Neoadjuvant chemotherapy and ovarian cancer
    Ray-Coquard, Isabelle
    Saba, Chadi
    Bachelot, Thomas
    Meeus, Pierre
    Mignotte, Herve
    Blondet, Remy
    Treilleux, Isabelle
    Peix, Marie
    Guastalla, Jean-Paul
    BULLETIN DU CANCER, 2006, 93 (07) : 669 - 676
  • [9] Neoadjuvant chemotherapy for ovarian cancer
    Vergote, I
    Van Gorp, T
    Amant, F
    Neven, P
    Berteloot, P
    ONCOLOGY-NEW YORK, 2005, 19 (12): : 1615 - 1622
  • [10] Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
    Hariprasad, Roopa
    Kumar, L.
    Kapoor, A.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 4 - +